Oxford’s PepGen Launches Into DMD With Next-Gen Oligonucleotide Platform

Aims To Challenge Sarepta

 
• By Andrew McConaghie
  
Caroline Godfrey
PepGen's chief executive Caroline Godfrey.
Scrip Podcast

Have you checked out Scrip podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip